Al Hammadi posts SAR 108 mln net profit in 2017

31/01/2018 Argaam Exclusive

View other reports

Share Price

Al Hammadi Holding
52.40
0.20 0.38 %

Al Hammadi Holding (ALHAMMADI)

More

Al Hammadi Company for Development and Investment reported a net profit of SAR 107.96 million for fiscal year 2017, a 47.97 percent year-on-year (YoY) increase.

 

The company said the increase in net profit is attributable to a 17 percent rise in revenue due to higher numbers of patients and optimized contractual terms with customers.



Financials (M)

Item 2016 2017 Change‬
Revenues 606.24 708.62 16.9 %
Gross Income 242.13 239.16 (1.2 %)
Operating Income 98.81 126.88 28.4 %
Net Income 72.96 107.97 48.0 %
Average Shares 160.00 160.00 -
EPS (Riyals) 0.46 0.67 48.0 %

The company posted a net profit of SAR 30.76 million in the fourth quarter of 2017.

 



Current Quarter Comparison (M)

Compared With The
Item Q4 2016 Q4 2017 Change‬
Revenues 182.65 188.69 3.3 %
Gross Income 73.35 65.08 (11.3 %)
Operating Income 18.58 33.93 82.6 %
Net Income 10.48 30.76 193.4 %
Average Shares 160.00 160.00 -
EPS (Riyals) 0.07 0.19 193.4 %


Financial results (Million)

Period Revenues Change Gross Income Change Net Income Change EPS(Riyal)
Q1 2008 - - - - - - -
Q2 2008 - - - - - - -
Q3 2008 - - - - - - -
Q4 2008 - - - - - - -
Q1 2009 - - - - - - -
Q2 2009 - - - - - - -
Q3 2009 - - - - - - -
Q4 2009 - - - - - - -
Q1 2010 - - - - - - -
Q2 2010 - - - - - - -
Q3 2010 - - - - - - -
Q4 2010 - - - - - - -
Q1 2011 - - - - - - -
Q2 2011 - - - - - - -
Q3 2011 - - - - - - -
Q4 2011 - - - - - - -
Q1 2012 - - - - - - -
Q2 2012 - - - - - - -
Q3 2012 - - - - - - -
Q4 2012 - - - - - - -
Q1 2013 104.84 - 47.34 - 29.83 - 0.19
Q2 2013 108.85 - 45.84 - 30.06 - 0.19
Q3 2013 96.26 - 36.81 - 18.32 - 0.11
Q4 2013 124.13 - 55.17 - 33.29 - 0.21
Q1 2014 122.04 16.4 % 54.71 15.6 % 34.23 14.7 % 0.21
Q2 2014 121.66 11.8 % 53.68 17.1 % 35.60 18.4 % 0.22
Q3 2014 108.83 13.1 % 44.74 21.5 % 25.42 38.7 % 0.16
Q4 2014 129.43 4.3 % 55.99 1.5 % 33.71 1.2 % 0.21
Q1 2015 129.48 6.1 % 50.64 (7.4 %) 41.01 19.8 % 0.26
Q2 2015 137.36 12.9 % 63.56 18.4 % 36.89 3.6 % 0.23
Q3 2015 136.80 25.7 % 57.97 29.6 % 27.69 8.9 % 0.17
Q4 2015 157.70 21.8 % 68.06 21.6 % 35.75 6.0 % 0.22
Q1 2016 144.16 11.3 % 54.75 8.1 % 21.14 (48.5 %) 0.13
Q2 2016 138.08 0.5 % 57.56 (9.5 %) 20.63 (44.1 %) 0.13
Q3 2016 141.35 3.3 % 56.48 (2.6 %) 20.73 (25.1 %) 0.13
Q4 2016 182.65 15.8 % 73.35 7.8 % 10.48 (70.7 %) 0.07
Q1 2017 180.23 25.0 % 62.02 13.3 % 27.97 32.3 % 0.17
Q2 2017 176.71 28.0 % 58.16 1.0 % 25.66 24.4 % 0.16
Q3 2017 163.01 15.3 % 53.91 (4.5 %) 23.59 13.8 % 0.15
Q4 2017 188.69 3.3 % 65.08 (11.3 %) 30.76 193.4 % 0.19
2017 708.62 16.9 % 239.16 (1.2 %) 107.97 48.0 % 0.67

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2008 - - -
Q2 2008 - - -
Q3 2008 - - -
Q4 2008 - - -
Q1 2009 - - -
Q2 2009 - - -
Q3 2009 - - -
Q4 2009 - - -
Q1 2010 - - -
Q2 2010 - - -
Q3 2010 - - -
Q4 2010 - - -
Q1 2011 - - -
Q2 2011 - - -
Q3 2011 - - -
Q4 2011 - - -
Q1 2012 - - -
Q2 2012 - - -
Q3 2012 - - -
Q4 2012 - - -
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 42.66 % 27.60 % 24.31 %
Q1 2014 42.66 % 27.85 % 24.35 %
Q2 2014 43.18 % 29.90 % 26.17 %
Q3 2014 43.70 % 30.34 % 26.97 %
Q4 2014 43.39 % 30.09 % 26.75 %
Q1 2015 41.90 % 29.13 % 25.73 %
Q2 2015 42.55 % 28.68 % 25.19 %
Q3 2015 42.80 % 29.71 % 24.29 %
Q4 2015 42.80 % 31.06 % 23.43 %
Q1 2016 42.42 % 30.79 % 21.09 %
Q2 2016 41.32 % 30.64 % 18.24 %
Q3 2016 40.74 % 29.96 % 16.90 %
Q4 2016 39.94 % 25.11 % 12.04 %
Q1 2017 38.83 % 24.74 % 12.43 %
Q2 2017 36.71 % 24.09 % 12.46 %
Q3 2017 35.22 % 23.41 % 12.48 %
Q4 2017 33.75 % 25.39 % 15.24 %
2017 33.75 % 25.39 % 15.24 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2008 - - - -
Q2 2008 - - - -
Q3 2008 - - - -
Q4 2008 - - - -
Q1 2009 - - - -
Q2 2009 - - - -
Q3 2009 - - - -
Q4 2009 - - - -
Q1 2010 - - - -
Q2 2010 - - - -
Q3 2010 - - - -
Q4 2010 - - - -
Q1 2011 - - - -
Q2 2011 - - - -
Q3 2011 - - - -
Q4 2011 - - - -
Q1 2012 - - - -
Q2 2012 - - - -
Q3 2012 - - - -
Q4 2012 - - - -
Q1 2013 160.00 - - 3.74
Q2 2013 160.00 - - 3.67
Q3 2013 160.00 - - 3.78
Q4 2013 160.00 0.70 0.66 3.66
Q1 2014 160.00 0.72 0.69 3.87
Q2 2014 160.00 0.76 0.76 7.88
Q3 2014 160.00 0.80 0.80 8.04
Q4 2014 160.00 0.81 0.81 8.25
Q1 2015 160.00 0.85 0.79 8.51
Q2 2015 160.00 0.86 0.80 8.27
Q3 2015 160.00 0.87 0.81 8.44
Q4 2015 160.00 0.88 0.82 8.66
Q1 2016 160.00 0.76 0.76 8.80
Q2 2016 160.00 0.66 0.66 8.37
Q3 2016 160.00 0.61 0.61 8.50
Q4 2016 160.00 0.46 0.46 8.56
Q1 2017 160.00 0.50 0.50 8.75
Q2 2017 160.00 0.53 0.53 8.89
Q3 2017 160.00 0.55 0.55 9.04
Q4 2017 160.00 0.67 0.67 8.67

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2008 - - -
Q2 2008 - - -
Q3 2008 - - -
Q4 2008 - - -
Q1 2009 - - -
Q2 2009 - - -
Q3 2009 - - -
Q4 2009 - - -
Q1 2010 - - -
Q2 2010 - - -
Q3 2010 - - -
Q4 2010 - - -
Q1 2011 - - -
Q2 2011 - - -
Q3 2011 - - -
Q4 2011 - - -
Q1 2012 - - -
Q2 2012 - - -
Q3 2012 - - -
Q4 2012 - - -
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 More than 50 More than 50 5.14
Q4 2014 48.92 48.92 4.78
Q1 2015 More than 50 More than 50 5.14
Q2 2015 More than 50 More than 50 5.61
Q3 2015 44.33 47.69 4.57
Q4 2015 41.63 44.73 4.24
Q1 2016 36.41 36.41 3.14
Q2 2016 45.86 45.86 3.60
Q3 2016 36.32 36.32 2.62
Q4 2016 More than 50 More than 50 3.64
Q1 2017 More than 50 More than 50 3.50
Q2 2017 More than 50 More than 50 3.49
Q3 2017 47.94 47.94 2.91
Q4 2017 41.25 41.25 3.21

Business Segments (Million)

Compared With The
Period healthy services and other Pharmaceutical sales revenue - Pharmacies
Q1 2017 150.74 29.49
Q2 2017 147.45 29.26
Q3 2017 136.70 26.31
Q4 2017 155.95 32.73

Analysts Estimates (Million)

Item Q4 2017 (e) Q4 2017 (a) Change‬
Average 27.89 30.76 10.29 %

Estimates vs Actual (Million)

Item Q4 2017 (e) Q4 2017 (a) Change
Sico 30.00 30.76 2.5 %
Alistithmar Capital 29.20 30.76 5.3 %
AlJazira Capital 29.20 30.76 5.3 %
Al Rajhi Capital 28.00 30.76 9.8 %
OSOOL AND BAKHEET 27.50 30.76 11.8 %
SNB Capital 27.00 30.76 13.9 %
Arbah Capital 26.20 30.76 17.4 %
Albilad Capital 26.00 30.76 18.3 %


Financial Ratios
Current
Market Cap (M Riyal) 8,384.00
Enterprise Value (EV) (M) 8,460.43
Shares Outstanding ((M)) 160.00
EPS ( Riyal) (TTM) 1.79
Book Value (BV) ( Riyal) 11.58
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 30.00
P/E (TTM) 29.32
Price/book 4.52
Return on Average Assets (%) (TTM) 11.1
Return on Average Equity (%) (TTM) 15.9
more

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.